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ORIGINAL PAPER/OBSTETRICS
Potential of DNA zygosity tests for non-invasive evaluation of risk of complications in 
twin pregnancies
Agnieszka Dziennik, Krzysztof Preis, Malgorzata Swiatkowska-Freund, Krzysztof Rebala





Objectives: To evaluate and compare the potential of DNA analysis and ultrasound 
examination for diagnosis of high-risk and low-risk twin pregnancies.
Material and methods: Chorionicity of 42 twin pregnancies was determined by routine high-
resolution sonographic examination between 10 and 14 weeks of gestation. Zygosity was 
analysed in umbilical cord blood samples collected immediately after the birth by genotyping 
of 22 autosomal short tandem repeats used in human identity testing.
Results: Routine ultrasound imaging in the first trimester of twin gestations revealed 21 low-
risk dichorionic (50%) and 21 high-risk monochorionic pregnancies (50%). DNA typing of 
umbilical cord blood showed 23 twin pairs with different genotypes (low-risk dizygotic 
pregnancies, 55%) and 19 twin pairs with identical genotypes (high-risk monozygotic 
pregnancies, 45%). We found four pregnancies (10%), which were diagnosed sonographically
as monochorionic diamniotic, but were identified as dizygotic in postnatal DNA testing. They 
constituted 19% of all high-risk monochorionic pregnancies detected by ultrasound imaging.
Conclusions: Our results indicate high potential of prenatal DNA testing of zygosity in 
identification of low-risk and high-risk twin gestations requiring different prenatal care, 
especially in cases when chorionicity and zygosity cannot be reliably determined by 
ultrasound examination and as a supplementary test able to detect gestations misdiagnosed as 
monochorionic, resulting from fusions of dizygotic placentas. In such cases, dizygosity 
detected prenatally eliminates the need for frequent prenatal visits typical for monochorionic 
pregnancies. If chorionicity cannot be unequivocally determined and a prenatal DNA test 
detects monozygotic twins, a more pessimistic variant of monochorionic pregnancy should 
always be assumed.
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INTRODUCTION
Owing to a high rate of complications, twin pregnancies are regarded as pathological 
in humans. In Europe, they are related to nine-fold higher risk of preterm birth, twelve-fold 
higher risk of very preterm birth and seven-fold higher risk of neonatal death in comparison to
singletons [1]. Moreover, incidence of twin pregnancies has grown dramatically over the last 
several decades as a result of the increase of the maternal age at conception and introduction 
of assisted reproduction techniques [2, 3]. In 2010, the twinning rate in Europe ranged from 
1:110 in Romania up to 1:38 in Cyprus [1], which makes a twin pregnancy a very common 
challenge of contemporary prenatal medicine.
General classification of twin pregnancies is based on the number of zygotes from 
which the twin foeti develop (dizygotic/DZ or monozygotic/MZ), the number of placental 
masses (dichorionic/DC or monochorionic/MC) and the number of amniotic sacs 
(diamniotic/DA or monoamniotic/MA) [4]. DZ pregnancies are almost always DC DA with 
each foetus having its own placenta and amniotic cavity. On the other hand, chorionicity and 
amniocity of MZ pregnancies is determined by the time at which division of an embryo 
occurs [5]. Thus, fertilisation of one ovum by one sperm leading to MZ twin pregnancy may 
result in DC DA (division within 4 days of conception), MC DA (division between 4 and 8 
days after conception) or MC MA gestation (division between 8 and 12 days after conception)
[4].
Chorionicity of twin pregnancies is diagnosed routinely by high-resolution ultrasound 
examination based on the number of placental masses, intertwin membrane thickness and the 
presence or absence of lambda or T sign between 10 and 14 weeks [6]. It is assumed that 
knowledge of chorionicity is paramount when managing a twin pregnancy [7] as far as MC 
pregnancies have 3–5 times higher perinatal morbidity and mortality in comparison to DC 
pregnancies [8]. However, considering MC pregnancies develop only in case of MZ twin 
foeti, a prognostic value for the course of a twin pregnancy may be provided also by a DNA 
test determining pregnancy zygosity, especially when chorionicity cannot be reliably 
determined [9]. Mortality of foeti is at least 2.5 times higher in MZ than in DZ twin 
pregnancies [10, 11], and it this is mainly due to complications in MC pregnancies, which 
constitute roughly two-thirds of MZ twin pregnancies [12]. Recently, several techniques have 
been developed for non-invasive prenatal twin zygosity testing of cell-free foetal DNA 
circulating in maternal plasma, based on sequencing of single nucleotide polymorphisms [13–
15], sequencing of microhaplotypes [16] and genotyping of multiallelic microsatellites [9].
Objectives
The aim of our study was to evaluate and compare the potential of DNA analysis and 
ultrasound examination for diagnosis of high-risk and low-risk twin pregnancies. For the 
purpose of our study, zygosity of 42 twin pregnancies was determined immediately after the 
birth and confronted with results of routine ultrasound examination of pregnancy chorionicity 
in the first trimester of gestation.
MATERIAL AND METHODS
A total of 42 women with twin pregnancies were involved in the study. They were 
patients of the Department of Obstetrics at the Medical University of Gdańsk and of the 
Department of Obstetrics and Gynaecology at the St. Adalbert Hospital in Gdańsk, 
Copernicus Podmiot Leczniczy Sp. z o.o. The study was approved by the Independent 
Bioethics Commission for Research at the Medical University of Gdańsk, and all patients 
provided their informed written consent for participation in the study. Chorionicity was 
determined by an attending physician dedicated to obstetric ultrasound during routine high-
resolution sonographic examination between 10 and 14 weeks of gestation, based on the 
number of placental masses, the intertwin membrane thickness and the presence or absence of
lambda or T sign [6]. Immediately after delivery, about 1.5 mL of umbilical cord blood was 
collected from each twin (84 samples in total) from the side of a placenta after cutting an 
umbilical cord. DNA was isolated from the umbilical cord blood samples with the use of a 
non-enzymatic method [17]. DNA concentration was measured spectrophotometrically with 
the use of an ND-1000 spectrophotometer (NanoDrop Technologies, Rockland, DE, USA). A 
total of 22 autosomal short tandem repeats (STRs), one Y-chromosomal STR and a gender 
marker (amelogenin) were amplified with the use of a commercial PowerPlex Fusion kit 
(Promega, Madison, WI, USA) and a Mastercycler Gradient thermal cycler (Eppendorf, 
Hamburg, Germany) in a total volume of 5 μL, containing 1 ng of DNA. Amplification 
products were suspended in Super-DI Formamide (MCLAB, South San Francisco, CA, USA),
mixed with ILS 500 size standard (Promega), denatured and analysed by capillary 
electrophoresis in a 3130 Genetic Analyzer (Applied Biosystems) with the use of NanoPOP-4 
polymer (MCLAB) and a 36-cm 4-capillary array. Genotypes of the analyzed samples were 
determined with the use of GeneMapper ID software v3.2 (Applied Biosystems) by 
comparison to an allelic ladder provided with the PowerPlex Fusion kit.
RESULTS
Routine ultrasound imaging in the first trimester of twin gestations revealed 21 DC 
DA (50.0%) and 21 MC pregnancies (50.0%). Among 21 MC pregnancies, there were 17 DA 
pregnancies (81.0%), 2 MA pregnancies (9.5%) and 2 pregnancies with unknown amniocity.
Human identity testing by STR typing of samples of the umbilical cord blood from 
twins coming from 42 pregnancies showed 23 twin pairs with different genotypes (DZ 
pregnancies, 54.8%) and 19 twin pairs with identical genotypes (MZ pregnancies, 45.2%; 
Tab. 1). Among 19 MZ pregnancies, there were 2 DC DA pregnancies (10.5%) and 17 MC 
pregnancies (89.5%), including 13 MC DA pregnancies (68.4%), 2 MC MA pregnancies 
(10.5%) and 2 MC pregnancies with unknown amniocity. On the other hand, among 23 DZ 
pregnancies, 19 pregnancies were diagnosed by ultrasound examination as DC DA (82.6%). 
Remaining 4 DZ pregnancies were identified by physicians dedicated to obstetric ultrasound 
as MC DA (17.4%) and constituted 19.0% of all high-risk MC pregnancies detected by 
ultrasound imaging.
DISCUSSION
Chorionicity is the main determinant of the perinatal outcome in twin pregnancies as 
far as perinatal morbidity and mortality are much higher in MC than DC pregnancies. This is 
mainly due to complications associated with monochorionicity, resulting from development of
intertwin vascular anastomoses in the shared placenta and including twin-to-twin transfusion 
syndrome, twin reversed arterial perfusion sequence and selective intrauterine growth 
restriction. Therefore, the accurate prenatal diagnosis of chorionicity is of major clinical 
importance in the management of twin pregnancies as far as it allows provision of increased 
surveillance in MC pregnancies and detection of complications in their early stages [7]. 
Ultrasound examination performed every two weeks of MC pregnancy is more likely to result
in early diagnosis of twin-to-twin transfusion syndrome in comparison to traditional monthly 
assessment, regarded as sufficient for management of DC pregnancies [4]. Moreover, in order 
to minimise perinatal deaths, delivery should be considered earlier in MC than DC 
pregnancies (36 vs 37 weeks of gestation) [18].
However, ascertainment of twin pregnancy chorionicity by ultrasound examination 
may be problematic when a pregnant woman misses her early gestation scan, when she is 
obese or when amniotic fluid volume is reduced [19]. Furthermore, there are cases of MC 
pregnancies with the visualised lambda sign between 10 and 14 weeks of gestation, thus 
incorrectly diagnosed as low-risk DC pregnancies [20]. Reverse misdiagnoses of DC as MC 
pregnancies prior to 14 weeks of gestation are also encountered in medical practice [21]. In 
our study, as much as 10% of pregnancies (4 cases) were misdiagnosed during the early 
ultrasound scan as high-risk MC gestations, but were found to be DZ by DNA testing, which 
may be explained as a result of fusion of DZ placentas [22]. These four misdiagnoses were 
made at two different obstetric units in Gdańsk by different physicians dedicated to obstetric 
ultrasound and with the use of different equipment, which excludes systematic error of one 
examiner as explanation of the observed discrepancies. It should be noted that dizygosity 
detected prenatally eliminates the need for precise ultrasound chorionicity assessment and 
frequent prenatal visits as far as DZ twins are DC even in case of fused placentas which 
generally do not form anastomoses resulting in twin-to-twin transfusion syndrome, as 
observed in MC pregnancies [23]. On the other hand, if chorionicity cannot be unequivocally 
determined, prenatal diagnosis of MZ pregnancy does not solve the problem of planned care 
for a pregnant woman. In such cases, a more pessimistic variant of MC pregnancy should 
always be assumed as far as it is safer to examine a pregnant woman unnecessarily every two 
weeks than to detect complications too late.
If evaluation of chorionicity is unclear, approximately 50% of DZ pregnancies may be 
identified as low-risk DC pregnancies by ultrasound examination in the mid-pregnancy, based
on opposite sex of twins. Although determination of sex of foeti is possible also in the first 
trimester, it is characterised by high risk of incorrect assignments [24]. However, a number of 
cases of post-zygotic disjunction in MC pregnancies, resulting in twin foeti of opposite sex, 
have been described [25–27]. Two separate placental masses are also indicative of low-risk 
DC pregnancy, but they are seen only in about one-third of twin pregnancies [4]. On the other 
hand, in European populations, as much as two-third of twin pregnancies are DZ [28, 29]. 
Thus, a sensitive and specific DNA test determining pregnancy zygosity, carried out alone in 
the early or middle pregnancy, restricts high-risk twin gestation diagnosis to 33% of twin 
pregnancies which are MZ. Although sonographic evaluation of chorionicity distinguishes 
more accurately high-risk and low-risk twin pregnancies, limiting high-risk twin gestation 
diagnosis to 25% of twin pregnancies which are MC [4], we have identified in our study as 
much as 10% of cases misdiagnosed sonographically as high-risk MC pregnancies, which 
could have been managed from the very beginning as low-risk pregnancies if a prenatal DNA 
test of zygosity had been available and performed.
A certain limitation of our study is the fact that zygosity of twins was evaluated 
postnatally, whereas currently available DNA tests for prenatal zygosity testing may be 
characterised by lower sensitivity of correct diagnosis of zygosity and by higher DNA input 
requirements [9, 13, 14]. However, the aim of our study was not to assess robustness and 
accuracy of a chosen DNA-based prenatal zygosity testing technique, but to evaluate general 
potential of DNA zygosity tests for non-invasive evaluation of risk of complications in twin 
pregnancies. Our results demonstrate that highly sensitive and specific DNA tests for prenatal 
diagnostics of twin pregnancy zygosity are needed and should be further developed.
CONCLUSIONS
Our study based on postnatal twin pregnancy zygosity testing, confronted with results 
of ultrasound examination in the first trimester, indicate a high potential of prenatal DNA 
testing of zygosity in identification of low-risk and high-risk twin gestations requiring 
different prenatal care in clinical practice, especially in cases when chorionicity and zygosity 
cannot be reliably determined by ultrasound examination and as a supplementary test able to 
detect gestations misdiagnosed as MC, resulting from fusions of DZ placentas. In such cases, 
dizygosity detected prenatally eliminates the need for frequent prenatal visits typical for MC 
pregnancies. If chorionicity cannot be unequivocally determined and a prenatal DNA test 
detects MZ twins, a more pessimistic variant of MC pregnancy should always be assumed.
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Table 1. Classification of 42 twin pregnancies by zygosity, chorionicity and amniocity, as 
revealed by postnatal hort tandem repeat typing and routine ultrasound examination in the 
first trimester of gestation
Zygosity Chorionicity Amniocity
Dizygotic 23 (55%) Dichorionic 19 (45%) Diamniotic 19 (45%)
Monochorionic 4 (10%) Diamniotic 4 (10%)
Monozygotic 19 (45%) Dichorionic 2 (5%) Diamniotic 2 (5%)
Monochorionic 17 (40%) Diamniotic 13 (31%)
Monoamniotic 2 (5%)
Unknown 2 (5%)
